Greeting from Lecturer YoshikiShibaAssistant professor

With the development of Precision Medicine using cancer panel testing and advances in tumour immunology, cancer treatment has entered a new era and is even more specialised than before. Nagoya University, a core hospital for cancer genome medicine, boasts one of the largest caseloads in the country and conducts clinical and research work at a high level.
Compared with other organs, brain tumours have limited effective drugs and the prognosis has not improved as much as expected. In other words, however, it is a very challenging field with a large potential for growth in clinical practice and research.
Let's work hard together to eradicate this powerful enemy.